Skip to content
Clinical Trials – home
EstoniaBack to Estonia

Clinical trials in Mustamae Linnaosa

7 clinical trials in Mustamae Linnaosa, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.

EstoniaOur site in EstoniaKliinilisedUuringud.ee(opens in a new tab)
Mustamae Linnaosa at a glance
7
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Mustamae Linnaosa

Open in trial search

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Rheumatoid arthritis

Not recruiting

Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Pneumonia

Not recruiting

Study on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:0–17 years
  • Substances:Ceftolozane
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm malignant

Not recruiting

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer Consumer Care AG

Other cities in Estonia

The busiest research cities in the country

All 11 cities in Estonia

Clinical research in Mustamae Linnaosa

What the registry says about research in the country

01 Oncology Research

Clinical studies focusing on darolutamide treatment for cancer patients, alongside groundbreaking research in esophageal carcinoma treatment combining chemoradiotherapy with innovative therapeutic approaches.

  • Cancer Treatment Continuity
  • Esophageal Cancer Therapy
  • Treatment Safety Evaluation

These trials aim to advance cancer treatment options and improve patient outcomes through targeted therapies.

02 Infectious Diseases

Innovative research examining the effectiveness of ceftolozane/tazobactam in treating pediatric patients with nosocomial pneumonia, focusing on safety profiles and treatment responses.

  • Hospital-Acquired Pneumonia
  • Pediatric Treatment Solutions
  • Antibiotic Safety Studies

These studies aim to enhance treatment options for young patients with hospital-acquired infections.

03 Hematology & Rheumatology

Comprehensive research programs investigating treatments for Acute Lymphoblastic Leukaemia in young patients and evaluating upadacitinib for rheumatoid arthritis management.

  • Leukemia Treatment in Young Patients
  • Rheumatoid Arthritis Therapy
  • Immunotherapy Advances

These trials focus on improving survival rates and quality of life for patients with blood disorders and autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.